These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
38 related articles for article (PubMed ID: 8795510)
1. Outcomes and resource utilization in a managed care setting for lower extremity vein bypass grafts. Maini BS; Orr RK; O'Mara P; Hendershott T Am J Surg; 1996 Aug; 172(2):113-6; discussion 117. PubMed ID: 8795510 [TBL] [Abstract][Full Text] [Related]
2. The value of adjunctive vein patches to improve the outcome of femorodistal polytetrafluoroethylene bypass grafts. Flis V; Pavlović M; Miksic K Wien Klin Wochenschr; 2001; 113 Suppl 3():5-10. PubMed ID: 15503612 [TBL] [Abstract][Full Text] [Related]
3. [Long-term patency of reversed and in situ femoro-popliteal bypasses]. Marković DM; Davidović LB; Lotina SI; Kostić DM; Cinara IS; Svetković SD; Marković M; Zivanović N Srp Arh Celok Lek; 1999; 127(11-12):365-70. PubMed ID: 10686817 [TBL] [Abstract][Full Text] [Related]
8. Prejudices and realities in the use of 'unsuitable' saphenous vein graft for infrapopliteal revascularization. Siani A; Accrocca F; Antonelli R; Giordano GA; Gabrielli R; Siani LM; Baldassarre E; Mounyergi F; Marcucci G G Chir; 2008; 29(6-7):261-4. PubMed ID: 18544261 [TBL] [Abstract][Full Text] [Related]
9. Arm vein as a last autogenous option for infrainguinal bypass surgery: it is worth the effort. Varcoe RL; Chee W; Subramaniam P; Roach DM; Benveniste GL; Fitridge RA Eur J Vasc Endovasc Surg; 2007 Jun; 33(6):737-41. PubMed ID: 17293130 [TBL] [Abstract][Full Text] [Related]
10. Long-term prognosis of femoropopliteal bypass: an analysis of 349 consecutive revascularizations. Lau H; Cheng SW ANZ J Surg; 2001 Jun; 71(6):335-40. PubMed ID: 11409017 [TBL] [Abstract][Full Text] [Related]
11. Polytetrafluoroethylene use for above-knee femoropopliteal bypass in critical limb ischemia. El-Kayali AA Saudi Med J; 2003 Jun; 24(6):669-71. PubMed ID: 12847601 [TBL] [Abstract][Full Text] [Related]
12. Infrapopliteal composite bypass with autologous vein and second generation glutaraldehyde stabilized human umbilical vein (HUV) for critical lower limb ischaemia. Neufang A; Espinola-Klein C; Dorweiler B; Savvidis S; Schmiedt W; Vahl CF Eur J Vasc Endovasc Surg; 2007 Nov; 34(5):583-9. PubMed ID: 17574877 [TBL] [Abstract][Full Text] [Related]
13. Finding autogenous veins for reoperative lower extremity bypasses: limitations of veins other than the greater saphenous. Chang BB; Shah DM; Leather RP; Darling RC Semin Vasc Surg; 1994 Sep; 7(3):173-7. PubMed ID: 7812492 [No Abstract] [Full Text] [Related]
14. Recanalization of totally occluded femoropopliteal vein grafts with low-dose streptokinase infusion. Hargrove WC; Berkowitz HD; Freiman DB; McLean G; Ring EJ; Roberts B Surgery; 1982 Nov; 92(5):890-5. PubMed ID: 6215728 [No Abstract] [Full Text] [Related]
15. Prostaglandin E1 as an adjuvant therapy in the event of femoropopliteal and crural great saphenous vein in situ bypass surgery. Fietze-Fischer B; Gruss JD; Bartels D; Vargas-Montano H; Stritter W Vasa Suppl; 1987; 17():23-5. PubMed ID: 3470961 [No Abstract] [Full Text] [Related]
20. Clinical Effect of Revascularization Strategies and Pharmacologic Treatment on Long-Term Results in Patients with Advanced Peripheral Artery Disease with TASC C and D Femoropopliteal Lesions. Lee CY J Interv Cardiol; 2022; 2022():3741967. PubMed ID: 35317345 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]